S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
SHOCKING Crypto Leak… (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Urgent alert: open this for a huge profit potential (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
SHOCKING Crypto Leak… (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Urgent alert: open this for a huge profit potential (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
SHOCKING Crypto Leak… (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Urgent alert: open this for a huge profit potential (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
SHOCKING Crypto Leak… (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Urgent alert: open this for a huge profit potential (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
Free Trial
ASX:TLX

Telix Pharmaceuticals (TLX) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free TLX Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
746,789 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
TLX stock logo

About Telix Pharmaceuticals Stock (ASX:TLX)

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and related medical devices for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. Its lead products include TLX591-CDx for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX250-CDx that is in Phase III clinical trials for the treatment and diagnosis of renal (kidney) cancer; TLX101-CDx for the diagnosis and treatment of glioblastoma (brain cancer); TLX66-CDx to treat bone marrow conditioning and rare diseases; TLX300-CDx for the treatment and diagnosis of soft tissue sarcoma; TLX250, which is in Phase II clinical trials for the diagnosis and treatment of kidney cancer; TLX591, which is in Phase III clinical trials for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX101 that is in Phase II clinical trials for the treatment of glioblastoma (brain cancer); TLX66, which is in Phase II clinical trials for the treatment of bone marrow conditioning and rare diseases; and TLX300 that is in Phase I clinical trial for the treatment and diagnosis of soft tissue sarcoma. The company also develops TLX592, a prostate cancer therapy candidate for targeted alpha therapy; and TLX599-CDx for treatment of prostate cancer imaging agent. The company was founded in 2015 and is headquartered in North Melbourne, Australia.

TLX Stock News Headlines

April 18, 2024 | fool.com.au
Why is the Telix share price jumping 15% to a record high?
April 17, 2024 | finanznachrichten.de
Telix Pharmaceuticals Limited: Q1 2024 Revenue and Business Update
April 20, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
April 17, 2024 | finance.yahoo.com
Q1 2024 Revenue and Business Update
April 16, 2024 | finance.yahoo.com
QSAM ANNOUNCES REVERSE STOCK SPLIT RATIO AHEAD OF MERGER
April 15, 2024 | msn.com
'Critical unmet need': Why everyone is talking about this ASX 200 healthcare stock
April 4, 2024 | msn.com
Why Aurelia Metals, Elders, GQG, and Telix shares are storming higher today
March 27, 2024 | finance.yahoo.com
World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain
April 20, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
March 12, 2024 | wsj.com
Telix Pharmaceuticals Ltd.
March 4, 2024 | finanznachrichten.de
Telix Pharmaceuticals Limited: Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
February 22, 2024 | msn.com
Inaugural profit overlooked as R&D spending soars at Telix Pharmaceuticals
February 22, 2024 | finance.yahoo.com
Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline
February 8, 2024 | finanznachrichten.de
QSAM Biosciences Inc.: QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
February 7, 2024 | finance.yahoo.com
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
February 7, 2024 | finance.yahoo.com
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
February 2, 2024 | fool.com.au
2 top ASX growth shares to buy right now and hold for the long term
January 22, 2024 | finance.yahoo.com
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)
January 4, 2024 | finance.yahoo.com
Telix Announces Planned Registered Public Offering and Listing in the United States
January 4, 2024 | finance.yahoo.com
UPDATE 2-Australia's Telix Pharmaceuticals jumps on potential US listing
January 4, 2024 | ca.finance.yahoo.com
Australia's Telix Pharmaceuticals jumps on potential US listing
January 3, 2024 | finance.yahoo.com
Telix to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 18, 2023 | finanznachrichten.de
Telix Pharmaceuticals Limited: Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix) for Imaging of Kidney Cancer
December 18, 2023 | finance.yahoo.com
Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix™) for Imaging of Kidney Cancer
December 4, 2023 | finance.yahoo.com
First Patient Dosed in European Named Patient (Early Access) Program for TLX250-CDx, Telix's Kidney Cancer Imaging Agent
November 29, 2023 | finanznachrichten.de
Telix Pharmaceuticals Limited: Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS
November 29, 2023 | finance.yahoo.com
Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS
See More Headlines
Receive TLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:TLX
CUSIP
N/A
CIK
N/A
Web
www.telixpharma.com
Phone
61 4 4914 8448
Fax
N/A
Employees
234
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A$0.02
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$5.21 million
Net Margins
1.04%
Pretax Margin
N/A
Return on Equity
4.55%
Return on Assets
9.92%

Debt

Debt-to-Equity Ratio
11.72
Current Ratio
1.43
Quick Ratio
3.00

Sales & Book Value

Annual Sales
$502.55 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
8.35
Book Value
A$0.46 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
323,990,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
2.35
10 Best Cheap Stocks to Buy Now Cover
10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Christian P. Behrenbruch BEng(Hons) (Age 48)
    DPhil(Oxon), GAICD, J.D., M.B.A., MBA, Co-Founder, MD, Group CEO & Executive Director
    Comp: $669.24k
  • Mr. Darren Smith B.Bus. (Age 59)
    FCPA, M.B.A., Group Chief Financial Officer
    Comp: $571.17k
  • Dr. Andreas Kluge M.D.
    Ph.D., Chief Medical Advisor & Non-Executive Director
  • Mr. Richard Valeix M.B.A.
    Group Chief Commercial Officer
  • Mr. Darren Patti
    Group Chief Operating Officer
  • Dr. Michael Wheatcroft B.Sc.
    BSc(Hons), Ph.D., Ph.D., (Cantab), Chief Scientist
  • Mr. Craig Ulrick
    Chief Information Officer
  • Ms. Kyahn Williamson B.A.
    Senior Vice President of Corporate Communications & Investor Relations
  • Ms. Melanie Farris (AGIA
    ACG, ACIS) BComn, B.Com., GradDip, M.A.I.C., Senior VP of Global Governance, Risk & Compliance
  • Ms. Lena Moran-Adams L.L.B.
    Group General Counsel

Key Competitors

View All Competitors

Insiders


TLX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Telix Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Telix Pharmaceuticals investors own include ACADIA Pharmaceuticals (ACAD), Adverum Biotechnologies (ADVM), Aimmune Therapeutics (AIMT), ANI Pharmaceuticals (ANIP), AxoGen (AXGN), Biohaven (BHVN), bluebird bio (BLUE), Blueprint Medicines (BPMC), Calithera Biosciences (CALA) and Codexis (CDXS).

This page (ASX:TLX) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets